Driehaus Capital Management Portfolio holdings
Driehaus Capital Management is a growth equity manager founded in 1982 by Richard Driehaus, an American investor often called the father of momentum investing. Its stock funds look for companies whose earnings growth is picking up, on the view that markets tend to misprice shares after such a turn. Richard Driehaus later founded Driehaus Mutual Funds in 1996. The firm is majority-owned by Driehaus Capital Holdings, which belongs to entities related to its late founder, and its clients include pension plans, endowments, foundations, family offices and the Driehaus mutual funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$103M |
| 2 |
Credo Technology Group
CRDO
|
+$102M |
| 3 |
Vicor
VICR
|
+$83.8M |
| 4 |
Cipher Digital
CIFR
|
+$74.9M |
| 5 |
Ceco Environmental
CECO
|
+$72.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fabrinet
FN
|
+$240M |
| 2 |
Lumentum
LITE
|
+$130M |
| 3 |
Bloom Energy
BE
|
+$118M |
| 4 |
TSMC
TSM
|
+$114M |
| 5 |
Coherent
COHR
|
+$90.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.73% |
| 2 | Technology | 23.9% |
| 3 | Industrials | 20.73% |
| 4 | Financials | 9.01% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Fastly Inc
FSLY
$2.68B
| $46.7M | 0.27% |
2,544,406
+1,706,078
| +204% | +$37.1M |
2025 Q4
2 quarters
|
|
127
Ormat Technologies
ORA
$5.56B
| $46.2M | 0.27% |
424,510
-47,257
| -10% | -$5.86M |
2025 Q2
4 quarters
|
|
128
Kiniksa Pharmaceuticals
KNSA
$7.57B
| $45.9M | 0.27% |
718,199
+106,801
| +17% | +$5.54M |
2023 Q3
11 quarters
|
|
129
Cohu
COHU
$2.06B
| $45.6M | 0.26% |
617,323
+78,792
| +15% | +$3.94M |
2026 Q1
1 quarter
|
|
130
Affirm
AFRM
$22.1B
| $43.8M | 0.25% |
+537,519
| New | +$35.1M |
2026 Q2
0 quarters
|
|
131
Galicia Financial Group
GGAL
$4.78B
| $43M | 0.25% |
860,111
-207,098
| -19% | -$9.7M |
2023 Q1
13 quarters
|
|
132
Backblaze
BLZE
$489M
| $42.6M | 0.25% |
+2,688,044
| New | +$18.6M |
2026 Q2
0 quarters
|
|
133
LivaNova
LIVN
$5.03B
| $42.4M | 0.25% |
516,086
-27,631
| -5% | -$1.95M |
2025 Q3
3 quarters
|
|
134
Madrigal Pharmaceuticals
MDGL
$9.9B
| $41.9M | 0.24% |
78,094
-32,866
| -30% | -$16.8M |
2025 Q3
3 quarters
|
|
135
Lindblad Expeditions
LIND
$2.27B
| $41.4M | 0.24% |
1,467,275
+281,376
| +24% | +$5.94M |
2025 Q1
5 quarters
|
|
136
Matador Resources
MTDR
$6.62B
| $41.3M | 0.24% |
828,648
-360,406
| -30% | -$20.5M |
2026 Q1
1 quarter
|
|
137
Neptune Insurance Holdings
NP
$3.92B
| $40.9M | 0.24% |
+1,297,130
| New | +$35.2M |
2026 Q2
0 quarters
|
|
138
ATI
ATI
$24.9B
| $40.4M | 0.23% |
205,124
-7,610
| -4% | -$1.29M |
2025 Q4
2 quarters
|
|
139
Tapestry
TPR
$26B
| $40.4M | 0.23% |
276,085
+3,537
| +1% | +$507K |
2025 Q2
4 quarters
|
|
140
Teledyne Technologies
TDY
$29.6B
| $39.5M | 0.23% |
59,258
+7,213
| +14% | +$4.54M |
2024 Q4
6 quarters
|
|
141
Rubrik
RBRK
$22.8B
| $39.5M | 0.23% |
+492,208
| New | +$31M |
2026 Q2
0 quarters
|
|
142
Pricesmart
PSMT
$5.1B
| $39.2M | 0.23% |
200,527
+25,681
| +15% | +$4.28M |
2025 Q3
3 quarters
|
|
143
Design Therapeutics
DSGN
$670M
| $38.5M | 0.22% |
2,661,115
+916,128
| +53% | +$11.4M |
2024 Q4
6 quarters
|
|
144
Encore Capital Group
ECPG
$2.28B
| $38.2M | 0.22% |
+409,924
| New | +$33.4M |
2026 Q2
0 quarters
|
|
145
Ligand Pharmaceuticals
LGND
$6.18B
| $37.5M | 0.22% |
118,497
+328
| +0.3% | +$77.3K |
2024 Q3
7 quarters
|
|
146
Tidewater
TDW
$3.94B
| $37.2M | 0.22% |
558,352
-200,184
| -26% | -$15.9M |
2025 Q2
4 quarters
|
|
147
Celldex Therapeutics
CLDX
$2.26B
| $36.8M | 0.21% |
+989,442
| New | +$32M |
2026 Q2
0 quarters
|
|
148
Federal Signal
FSS
$7.04B
| $36.8M | 0.21% |
286,189
-53,253
| -16% | -$6.11M |
2022 Q3
15 quarters
|
|
149
NeoGenomics
NEO
$2.07B
| $36.6M | 0.21% |
2,508,845
+787,095
| +46% | +$7.6M |
2025 Q4
2 quarters
|
|
150
FuelCell Energy
FCEL
$774M
| $36.5M | 0.21% |
+1,014,687
| New | +$16.5M |
2026 Q2
0 quarters
|
|
Similar funds
Driehaus Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Driehaus Capital Management held 439 positions worth $17.3B, up 27% from $13.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Driehaus Capital Management's Q2 2026 filing shows 84 new, 139 increased, 108 reduced and 85 closed positions. Its largest new stake was Cadence Design Systems: 293,693 shares worth $110M. The largest sale was Fabrinet, an estimated $240M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
- Driehaus Capital Management's largest Q2 2026 buy was Cadence Design Systems: 293,693 shares worth $110M.
- Driehaus Capital Management added most to Vicor in Q2 2026, an estimated $83.8M increase.
- Driehaus Capital Management's biggest Q2 2026 reduction was Fabrinet, cutting an estimated $240M.
- Driehaus Capital Management fully exited National Vision in Q2 2026, selling an estimated $89.9M.
- Driehaus Capital Management's ten largest holdings make up 16% of its $17.3B portfolio in Q2 2026.
- Driehaus Capital Management opened 84 new positions and closed 85 in Q2 2026.
- Driehaus Capital Management's portfolio value rose 27% quarter-over-quarter to $17.3B.
Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.